News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
YINGLING JONATHAN MICHAEL
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/14/2020 |
4
| YINGLING JONATHAN MICHAEL (Chief Scientific Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 shares
@ $0
Granted 50,000 options to buy
@ $1.79, valued at
$89.5k
|
|
| 01/14/2020 |
4/A
| YINGLING JONATHAN MICHAEL (Chief Scientific Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Sold 1,742 shares
@ $1.7804, valued at
$3.1k
|
|
| 01/10/2020 |
4
| YINGLING JONATHAN MICHAEL (Chief Scientific Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Sold 1,742 shares
@ $1.7804, valued at
$3.1k
|
|
| 07/11/2019 |
4
| YINGLING JONATHAN MICHAEL (Chief Scientific Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 45,500 options to buy
@ $2.52, valued at
$114.7k
|
|
| 01/07/2019 |
4
| YINGLING JONATHAN MICHAEL (Chief Scientific Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 18,100 shares
@ $0
Granted 45,500 options to buy
@ $3.14, valued at
$142.9k
|
|
| 08/15/2018 |
4
| YINGLING JONATHAN MICHAEL (Chief Scientific Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 32,500 options
@ $7.39, valued at
$240.2k
|
|
| 01/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/08/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|